Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.

Trovagene, Inc.

announced the full exercise of the over-allotment option granted to the underwriters to purchase 172,500 additional units, at a public offering price of $8.00 per unit, in connection with its previously announced underwritten public offering of 1,150,000 units, bringing total gross proceeds from the offering to $10,580,000.